Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 228,398,554 papers from all fields of science
Search
Sign In
Create Free Account
dactolisib
Known as:
2-methyl-2-(4-(3-methyl-2-oxo-8-(quinolin-3-yl)-2,3-dihydroimidazo(4,5-c)quinolin-1-yl)phenyl)propanenitrile
, 2-methyl-2-(4-(3-methyl-2-oxo-8-quinolin-3-yl-2,3-dihydro-1h-imidazo(4,5-c)quinolin-1-yl)phenyl)propanenitrile
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
5 relations
Broader (3)
Antineoplastic Agents
Imidazoles
Quinolines
Narrower (2)
BEZ235
NVP BEZ235
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Oral TORC1 Inhibitor Dactolisib Enhances Immune Function and Reduces the Incidence of Respiratory Tract Infections in Elderly Subjects with Asthma
J. Mannick
,
S. Shergill
,
G. Teo
B15. IMMUNOTHERAPY FOR LUNG DISEASE
2019
Corpus ID: 202813246
2018
2018
Symbolic Regression Modeling of Drug Responses
Jake Fitzsimmons
,
P. Moscato
International Conference on Artificial…
2018
Corpus ID: 77390244
Big pharmaceutical companies require to innovate by applying new machine learning and artificial intelligence methods to…
Expand
2018
2018
Correction: The dual PI3K/mTOR inhibitor dactolisib elicits anti-tumor activity in vitro and in vivo
Fei Shi
,
Jinying Zhang
,
+6 authors
Hao Wu
OncoTarget
2018
Corpus ID: 4986145
[This corrects the article DOI: 10.18632/oncotarget.23091.].
2017
2017
Biological characterization of SN 32976 , a selective inhibitor of PI 3 K and mTOR with preferential activity to PI 3 K α , in comparison to established pan PI 3 K inhibitors
G. Rewcastle
,
Sharada V Kolekar
,
+14 authors
S. Jamieson
2017
Corpus ID: 29491590
Multiple therapeutic agents have been developed to target the phosphatidylinositol 3-kinase (PI3K) signaling pathway, which is…
Expand
2017
2017
DACTOLISIB-LOADED RECONSTITUTED HIGH DENSITY LIPOPROTEINS (RHDAL): A CANDIDATE FOR GLIOBLASTOMA THERAPY
T. M. Shaw
,
Ethan Berney B.S.
,
A. Lacko
2017
Corpus ID: 139726651
Despite substantial chemotherapeutic advances in the 21st century, toxicity remains a prevailing obstacle in cancer treatment…
Expand
2017
2017
Methods of enhancing immune response with everolimus, dactolisib or both
J. Mannick
,
M. Morris
2017
Corpus ID: 89935270
2016
2016
Dactolisib (NVP-BEZ235) toxicity in murine brain tumour models
I. A. Netland
,
H. Førde
,
+6 authors
D. Goplen
BMC Cancer
2016
Corpus ID: 255840793
Glioblastomas (GBMs) are highly malignant brain tumours with a poor prognosis, and current cytotoxic regimens provide only a…
Expand
2015
2015
Trametinib and dactolisib but not regorafenib exert antiproliferative effects on rat pancreatic stellate cells.
L. Witteck
,
R. Jaster
Hepatobiliary & Pancreatic Diseases International
2015
Corpus ID: 25784882
2015
2015
GENO-26IDENTIFICATION OF GENOMIC LESIONS ENRICHED IN LUNG CANCER BRAIN METASTASES
S. Michelhaugh
,
Aliccia Bollig-Fischer
,
S. Mittal
2015
Corpus ID: 76495472
BACKGROUND: The incidence of central nervous system metastasis from primary non-small cell lung cancer (NSCLC) has steadily…
Expand
2014
2014
Characterization of BK viral responses to the dual-PI3K/MTOR inhibitor dactolisib (NVP BEZ-235) in a renal cell culture model
G. Lerner
2014
Corpus ID: 77092786
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE